{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:08Z","timestamp":1786118888845,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/jcp.0b013e318172b49e","type":"journal-article","created":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T03:06:01Z","timestamp":1210302361000},"page":"340-344","source":"Crossref","is-referenced-by-count":110,"title":["Nicotinic Antagonist Augmentation of Selective Serotonin Reuptake Inhibitor-Refractory Major Depressive Disorder"],"prefix":"10.1097","volume":"28","author":[{"given":"Tony P.","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi A.","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Vessicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea H.","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Douglas","family":"Shytle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.62.10.1097","article-title":"Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"62","author":"Hasin","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archpsyc.62.2.165","article-title":"The relationship between antidepressant medication use and the rate of suicide.","volume":"62","author":"Gibbons","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R3-14-20210128","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/10550490590924728","article-title":"Co-morbidity of smoking with psychiatric and substance use disorders.","volume":"14","author":"Kalman","year":"2005","journal-title":"Am J Addict"},{"key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.mp.4001035","article-title":"Nicotinic acetylcholine receptors as targets for antidepressants.","volume":"7","author":"Shytle","year":"2002","journal-title":"Mol Psychiatry"},{"key":"R5-14-20210128","first-page":"387","article-title":"Antidepressant effect of transdermal nicotine patches in non-smoking patients with major depression.","volume":"57","author":"Salin-Pascual","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00213-006-0516-y","article-title":"Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial.","volume":"189","author":"McClernon","year":"2006","journal-title":"Psychopharmacology"},{"key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/nn1580","article-title":"Nicotine addiction and comorbidity with alcohol abuse and mental illness.","volume":"8","author":"Dani","year":"2005","journal-title":"Nat Neurosci"},{"key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","article-title":"A cholinergic-adrenergic hypothesis of mania and depression.","volume":"2","author":"Janofsky","year":"1972","journal-title":"Lancet"},{"key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0006-3223(00)00945-8","article-title":"Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine).","volume":"48","author":"Shytle","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/da.10035","article-title":"Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.","volume":"16","author":"Shytle","year":"2002","journal-title":"Depress Anxiety"},{"key":"R11-14-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/14622200210123581","article-title":"Biochemical verification of tobacco use and cessation. Report from the SRNT Subcommittee on Biochemical Verification.","volume":"4","author":"Benowitz","year":"2002","journal-title":"Nicotine Tob Res"},{"key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/da.10079","article-title":"Evidence that the SSRI dose response in treating major depression should be reassessed: a meta-analysis.","volume":"17","author":"Baker","year":"2003","journal-title":"Depress Anxiety"},{"key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1360-0443.1995.tb01041.x","article-title":"Stress modulation over the day in cigarette smokers.","volume":"90","author":"Parrott","year":"1995","journal-title":"Addiction"},{"key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2466\/pr0.94.1.33-34","article-title":"Heightened stress and depression follow cigarette smoking.","volume":"94","author":"Parrott","year":"2004","journal-title":"Psychol Rep"},{"key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an alpha4 beta2 nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained release bupropion for smoking cessation.","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b013e318172b49e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:01:57Z","timestamp":1786035717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200806000-00014"}},"subtitle":["A Preliminary Study"],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318172b49e","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}